ACO1 and melanoma: confirmed that erastin and RSL3 increased the expression of IRP1 and IRP2, knockdown of which conversely inhibited erastin- or RSL3-induce cell death, and IRP2 could enhance the promoting effect of IRP1 in melanoma cells (85).